Quick Answer
Gossamer Bio, Inc. reported Operating Income of -$170.73 million for fiscal year 2025.
Gossamer Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$170.73M | -184.9% |
| 2024 | -$59.92M | +67.4% |
| 2023 | -$183.76M | +15.9% |
| 2022 | -$218.59M | -1.1% |
| 2021 | -$216.12M | +7.6% |
| 2020 | -$233.96M | -25.7% |
| 2019 | -$186.14M | -24.9% |
| 2018 | -$148.99M | -2139.5% |
| 2017 | -$6.65M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$49.11M | -44.8% | -26.7% |
| June 30, 2025 | -$38.77M | -174.4% | -5.3% |
| March 31, 2025 | -$36.81M | +12.3% | -8.5% |
| September 30, 2024 | -$33.92M | +16.2% | -165.1% |
| June 30, 2024 | $52.09M | +212.5% | +224.1% |
| March 31, 2024 | -$41.96M | +12.5% | -3.6% |
| September 30, 2023 | -$40.49M | +27.7% | +12.5% |
| June 30, 2023 | -$46.30M | +14.1% | +3.4% |
- Gossamer Bio, Inc. showed a decrease of -184.9% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Gossamer Bio, Inc.’s operating income has declined by 2466.2% (from -$6.65 million to -$170.73 million).
- The most recent figure is from Gossamer Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: